Market Tracker

08/27 8:37am ET

Actavis PLC (NYSE:ACT)

227.72
Data as of Aug 26
 +1.11 / +0.49%
Today’s Change
130.06
Today|||52-Week Range
230.77
+35.55%
Year-to-Date

Today’s Trading

Previous close226.61
Today’s open227.34
Day’s range-- - --
Volume1,267,583
Average volume (3 months)2,399,322
Market cap$59.9B
Dividend yield--
Data as of 08/26/2014

Growth & Valuation

Earnings growth (last year)-793.42%
Earnings growth (this year)+39.76%
Earnings growth (next 5 years)+18.86%
Revenue growth (last year)+46.71%
P/E ratioNM
Price/Sales2.75
Price/Book4.14

Competitors

 Today’s
change
Today’s
% change
ABTAbbott Laboratories+0.31+0.73%
LLYEli Lilly and Co+0.08+0.13%
AGNAllergan Inc+0.56+0.34%
SHPGShire PLC+0.55+0.23%
Data as of 08/26/2014

Financials

Next reporting dateNovember 4, 2014
EPS forecast (this quarter)$3.09
Annual revenue (last year)$8.7B
Annual profit (last year)-$750.4M
Net profit margin-8.65%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts